Vitality AVT
This article was originally published in The Gray Sheet
Executive Summary
First human implant of the implantable cardioverter defibrillator takes place at University Hospital Dusseldorf Jan. 14, coinciding with CE mark approval of the device. The AVT builds on technology in Vitality DS ICD, which received European approval in July (1"The Gray Sheet" July 29, 2002, In Brief)...
You may also be interested in...
Guidant
Vitality DS ICD receives European CE mark approval. Guidant, which says the 30 cc Vitality is the world's smallest ICD, is currently in discussions with FDA about U.S. approval requirements...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.